Identification of V3 loop-binding proteins as potential receptors implicated in the binding of HIV particles to CD4+ cells

被引:67
作者
Callebaut, C
Blanco, J
Benkirane, N
Krust, B
Jacotot, E
Guichard, G
Seddiki, N
Svab, J
Dam, E
Muller, S
Briand, JP
Hovanessian, AG
机构
[1] Inst Pasteur, Unite Virol & Immunol Cellulaire, ERS 572 CNRS, F-75724 Paris 15, France
[2] Inst Biol Mol & Cellulaire, UPR 9021 CNRS, F-67084 Strasbourg, France
关键词
D O I
10.1074/jbc.273.34.21988
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The binding of human immunodeficiency virus (HIV) type 1 particles to CD4(+) cells could be blocked either by antibodies against the V3 loop domain of the viral external envelope glycoprotein gp120, or by the V3 loop mimicking pseudopeptide 5[K psi(CH2N)PR]-TASP, which forms a stable complier with a cell-surface-expressed 95-kDa protein, Here, by using an affinity matrix containing 5[K psi(CH2N)PR]-TASP and cytoplasmic extracts from human CEM cells, we purified three V3 loop-binding proteins of 95, 40, and 30 kDa, which after microsequencing were revealed to be as nucleolin, putative HLA class II-associated protein (PHAP) II, and PHAP I, respectively. The 95-kDa cell-surface protein was also isolated and found to be nucleolin, We show that recombinant preparations of gp120 bind the purified preparations containing the V3 loop-binding proteins with a high affinity, comparable to the binding of gp120 to soluble CD4, Such binding is inhibited either by 5[K psi(CH2N)PR]-TASP or antibodies against the V3 loop. Moreover, these purified preparations inhibit HIV entry into CD4+ cells as efficiently as soluble CD4, Taken together, our results suggest that nucleolin, PHAP II, and PHAP I appear to be functional as potential receptors in the HIV binding process by virtue of their capacity to interact with the V3 loop of gp120.
引用
收藏
页码:21988 / 21997
页数:10
相关论文
共 63 条
[1]  
ADACHI Y, 1994, J BIOL CHEM, V269, P2258
[2]   IDENTIFICATION OF THE U-937 MEMBRANE-ASSOCIATED PROTEINASE INTERACTING WITH THE V3 LOOP OF HIV-1 GP120 AS CATHEPSIN-G [J].
AVRIL, LE ;
DIMARTINOFERRER, M ;
PIGNEDE, G ;
SEMAN, M ;
GAUTHIER, F .
FEBS LETTERS, 1994, 345 (01) :81-86
[3]   Receptor-binding properties of a purified fragment of the 4070A amphotropic murine leukemia virus envelope glycoprotein [J].
Battini, JL ;
Rodrigues, P ;
Muller, R ;
Danos, O ;
Heard, JM .
JOURNAL OF VIROLOGY, 1996, 70 (07) :4387-4393
[4]   CROSS-REACTIVITY OF ANTIBODIES TO RETRO-INVERSO PEPTIDOMIMETICS WITH THE PARENT PROTEIN HISTONE H3 AND CHROMATIN CORE PARTICLE - SPECIFICITY AND KINETIC RATE-CONSTANT MEASUREMENTS [J].
BENKIRANE, N ;
GUICHARD, G ;
VANREGENMORTEL, MHV ;
BRIAND, JP ;
MULLER, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (20) :11921-11926
[5]   MAJOR NUCLEOLAR PROTEINS SHUTTLE BETWEEN NUCLEUS AND CYTOPLASM [J].
BORER, RA ;
LEHNER, CF ;
EPPENBERGER, HM ;
NIGG, EA .
CELL, 1989, 56 (03) :379-390
[6]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF(-) MUTANT PARTICLES FROM RESTRICTIVE CELLS - ROLE OF VIF IN CORRECT PARTICLE ASSEMBLY AND INFECTIVITY [J].
BORMAN, AM ;
QUILLENT, C ;
CHARNEAU, P ;
DAUGUET, C ;
CLAVEL, F .
JOURNAL OF VIROLOGY, 1995, 69 (04) :2058-2067
[7]   THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) CD4 RECEPTOR AND ITS CENTRAL ROLE IN PROMOTION OF HIV-1 INFECTION [J].
BOUR, S ;
GELEZIUNAS, R ;
WAINBERG, MA .
MICROBIOLOGICAL REVIEWS, 1995, 59 (01) :63-93
[8]   A LARGE ARRAY OF HUMAN MONOCLONAL-ANTIBODIES TO TYPE-1 HUMAN-IMMUNODEFICIENCY-VIRUS FROM COMBINATORIAL LIBRARIES OF ASYMPTOMATIC SEROPOSITIVE INDIVIDUALS [J].
BURTON, DR ;
BARBAS, CF ;
PERSSON, MAA ;
KOENIG, S ;
CHANOCK, RM ;
LERNER, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (22) :10134-10137
[9]   Inhibition of HIV infection by pseudopeptides blocking viral envelope glycoprotein-mediated membrane fusion and cell death [J].
Callebaut, C ;
Jacotot, E ;
Guichard, G ;
Krust, B ;
ReyCuille, MA ;
Cointe, D ;
Benkirane, N ;
Blanco, J ;
Muller, S ;
Briand, JP ;
Hovanessian, AG .
VIROLOGY, 1996, 218 (01) :181-192
[10]   Increased rate of HIV-1 entry and its cytopathic effect in CD4+/CXCR4+ T cells expressing relatively high levels of CD26 [J].
Callebaut, C ;
Jacotot, E ;
Blanco, J ;
Krust, B ;
Hovanessian, AG .
EXPERIMENTAL CELL RESEARCH, 1998, 241 (02) :352-362